Cannabis Science Inc (OTCMKTS:CBIS) a U.S. firm specializing in the advancement of cannabinoid-based drugs, has commenced its first cannabinoid medication development land agreement buildout in Douglas County. The preliminary phase of the buildout is prepared to comprise 33,000 square feet of greenhouse space.

The highlights

With a considerable area of land kept for greenhouse space, Cannabis Science can commence advancing for cannabinoid extractions rapidly, and in optimal conditions. It will allow the firm direct access to definite cannabinoid combinations for drug and research advancement, which will boost the procedure of getting more goods out to an ever-growing client base.

Additionally, to the greenhouse industry, the firm is working to decide the best site on the lands to establish and set Raymond C. Dabney University. It will be the main point of a self-sustaining community that underlines clinical and academic studies of law, agriculture, medicinal science and business as they link to cannabinoids and other application and study.

Raymond C. Dabney, the President and CEO of Cannabis Science, said that it is an incredible feeling to witness remarkable plans eventually coming to fruition. The company is hitting the ground moving, and soon they will be advancing specific cannabinoid blends with their associates to study and advance into a wide variety of new medications for self-medicating patients. It is the dawn of a new period for great firm.

Additionally, the firm’s grow associates in Nevada have been questioned by a regional ABC TV News partner, and it will be broadcasted soon. The property partners/owners are very thrilled to commence building with the increased publicity on the licensing processes, educational and economic growth prospects for their community.

Cannabis Science is all set to move in on new prospects in Nevada and California markets after the election cycle. The group is targeting almost 1,000 acres in Nevada and California for asset and medication advancement plans. The post-election strategy will focus on new goods, new dispensaries, and new strategic deals.